haloperidol and dantrolene

haloperidol has been researched along with dantrolene in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (30.23)	18.7374
1990's	16 (37.21)	18.2507
2000's	4 (9.30)	29.6817
2010's	8 (18.60)	24.3611
2020's	2 (4.65)	2.80

Authors

Authors	Studies
McLoughlin, JV; Wheatley, AM	1
Ettenberg, A; Hammond, EO; Torok, ML	1
Buades, J; Martínez, J; Pérez de Mendiola, MM; Usandizaga, I	1
Delerue, O; Destée, A	1
Chinyanga, HM; Constantinou, E; Haisma, HJ	1
Nolen, WA; Zwaan, WA	1
Hermesh, H; Munitz, H; Shalev, A	1
Munitz, H; Shalev, A	1
Mori, K; Morio, M; Yamawaki, S; Yanagawa, K	1
Jaffe, JH; Khan, A; Morrison, B; Nelson, WH	1
Lucid, EJ; Martin, ML; Walker, RW	1
Matsubara, S; Omori, T	1
Carbaat, PA; Goekoop, JG	1
Bismuth, C; de Rohan-Chabot, P; Goulon, M; Raphael, JC	1
Jerushalmi, Y; Konikoff, F; Kuritzky, A; Theodor, E	1
Gómez, EA	1
Bismuth, C; Conso, F; de Rohan-Chabot, P; Elkharrat, D; Gajdos, P; Goulon, M	1
Fenton, BJ; Gaffney, FA; May, DC; Morris, SW; Stewart, RM	1
Bismuth, C; Conso, F; de Rohan Chabot, P; Elkharrat, D; Goulon, M	1
Burke, C; Castellano, J; Fulda, GJ	1
Ishiguro, T; Matoba, M; Nisijima, K	1
Byrd, RP; Lukeman, RW; Mathai, M; Mathew, MK	1
Grande Rodríguez, S; Real Rodríguez, B; Ruibal, JL; Sueiro Pita, B	1
Hosono, T; Ikura, Y; Kudo, T; Niigawa, H; Nishimura, T; Sakamoto, S; Takeda, M; Taniguchi, N; Tanii, H	1
Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H	1
Collins, SP; Mendes, LS	1
Asanuma, M; Iwata, E; Kudo, T; Ogawa, N; Takeda, M; Taniguchi, N; Tanii, H; Tsujio, I	1
Deppe, S; Epperly, N; Friedman, B; Law, E; Orlet, H; Still, J	1
Barron, TF; Dayner, J; Trasmonte, J	1
Fiege, M; Gerbershagen, MU; Ito, WD; Schulte am Esch, J; Wappler, F	1
Keck, PE; Strawn, JR	1
Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC	1
Ikushima, G; Kameda, K; Koinuma, M; Shoko, T; Takahashi, K; Watarai, K	1
Fritzenwanger, M; Heymel, S; Pfeifer, R; Schulze, PC; Wystub, N	1
Rosini, JM; Whyte, CJ	1
Ishida, M; Kawakami, K; Kawanishi, C; Onishi, H; Sato, I; Yamada, S	1
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1

Reviews

6 review(s) available for haloperidol and dantrolene

Article	Year
Mortality from neuroleptic malignant syndrome. The Journal of clinical psychiatry, 1989, Volume: 50, Issue:1 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dantrolene; Dopamine Agents; Female; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Risk Factors; Substance-Related Disorders	1989
The neuroleptic malignant syndrome: agent and host interaction. Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4 Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome	1986
Neuroleptic malignant syndrome in a trauma patient. The Journal of trauma, 1995, Volume: 39, Issue:4 Topics: Adult; Antipsychotic Agents; Dantrolene; Droperidol; Haloperidol; Humans; Male; Multiple Trauma; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychomotor Agitation	1995
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam]. Anales espanoles de pediatria, 1996, Volume: 44, Issue:1 Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Dantrolene; Diazepam; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Lorazepam; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Time Factors	1996
Neuroleptic malignant syndrome in patients with cancer: a systematic review. BMJ supportive & palliative care, 2020, Volume: 10, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dantrolene; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Neoplasms; Neuroleptic Malignant Syndrome	2020
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

37 other study(ies) available for haloperidol and dantrolene

Article	Year
The effect of haloperidol, spiperone and dantrolene on the concentrations of creatine phosphate, ATP and lactate in brain and skeletal muscle of the rat during halothane anesthesia. Research communications in chemical pathology and pharmacology, 1991, Volume: 73, Issue:3 Topics: Adenosine Triphosphate; Anesthesia; Animals; Antipsychotic Agents; Brain Chemistry; Dantrolene; Female; Haloperidol; Halothane; Lactates; Lactic Acid; Muscles; Phosphocreatine; Rats; Rats, Inbred Strains; Spiperone	1991
Different patterns of behavior produced by haloperidol, pentobarbital, and dantrolene in tests of unconditioned locomotion and operant responding. Psychopharmacology, 1991, Volume: 104, Issue:2 Topics: Animals; Conditioning, Operant; Dantrolene; Food; Haloperidol; Male; Motor Activity; Pentobarbital; Rats; Rats, Inbred Strains; Reinforcement Schedule	1991
[Neuroleptic malignant syndrome]. Medicina clinica, 1990, Oct-06, Volume: 95, Issue:11 Topics: Adult; Biperiden; Chlormethiazole; Chlorpromazine; Dantrolene; Diazepam; Female; Haloperidol; Humans; Male; Methotrimeprazine; Neuroleptic Malignant Syndrome	1990
[Protracted recurrent neuroleptic malignant syndrome]. Revue neurologique, 1990, Volume: 146, Issue:8-9 Topics: Adult; Bromocriptine; Dantrolene; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Recurrence	1990
Neuroleptic malignant syndrome. The Central African journal of medicine, 1990, Volume: 36, Issue:5 Topics: Adult; Bromocriptine; Chlorpromazine; Dantrolene; Female; Haloperidol; Humans; Lithium; Neuroleptic Malignant Syndrome	1990
Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. Acta psychiatrica Scandinavica, 1990, Volume: 82, Issue:1 Topics: Adolescent; Catatonia; Combined Modality Therapy; Dantrolene; Diazepam; Electroconvulsive Therapy; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome	1990
Possible central effect of dantrolene sodium in neuroleptic malignant syndrome. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:6 Topics: Brain; Dantrolene; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders	1986
Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. The Journal of clinical psychiatry, 1985, Volume: 46, Issue:6 Topics: Basal Ganglia Diseases; Bipolar Disorder; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Neuroleptic Malignant Syndrome	1985
Neuroleptic malignant syndrome. Annals of emergency medicine, 1985, Volume: 14, Issue:4 Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome	1985
Rapid cooling contracture in frog striated muscles treated with chlorpromazine and haloperidol. The Japanese journal of physiology, 1985, Volume: 35, Issue:2 Topics: Animals; Caffeine; Chlorpromazine; Cold Temperature; Dantrolene; Haloperidol; Muscle Contraction; Muscles; Procaine; Ranidae; Time Factors; Toes	1985
Treatment of neuroleptic malignant syndrome with dantrolene. Lancet (London, England), 1982, Jul-03, Volume: 2, Issue:8288 Topics: Adult; Bipolar Disorder; Dantrolene; Haloperidol; Humans; Male; Malignant Hyperthermia; Muscle Rigidity	1982
Dantrolene--a new therapeutic approach to the neuroleptic malignant syndrome. Acta neurologica Scandinavica. Supplementum, 1984, Volume: 100 Topics: Adolescent; Adult; Basal Ganglia Diseases; Dantrolene; Haloperidol; Heat Exhaustion; Humans; Hypertension, Malignant; Male; Neuroleptic Malignant Syndrome; Phenothiazines	1984
Neuroleptic malignant syndrome induced by a single injection of haloperidol. British medical journal (Clinical research ed.), 1984, Nov-03, Volume: 289, Issue:6453 Topics: Basal Ganglia Diseases; Dantrolene; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome	1984
[Extrapyramidal reactions and neuroleptic malignant syndrome]. Acta psiquiatrica y psicologica de America latina, 1984, Volume: 30, Issue:4 Topics: Adult; Amantadine; Basal Ganglia Diseases; Dantrolene; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary	1984
Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. Neurology, 1983, Volume: 33, Issue:4 Topics: Adolescent; Adult; Basal Ganglia Diseases; Dantrolene; Fever; Haloperidol; Humans; Male; Muscle Rigidity; Schizophrenia	1983
Neuroleptic malignant syndrome: response to dantrolene sodium. Annals of internal medicine, 1983, Volume: 98, Issue:2 Topics: Dantrolene; Fever; Haloperidol; Humans; Male; Middle Aged; Muscle Rigidity; Syndrome	1983
[Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)]. La Nouvelle presse medicale, 1982, Mar-27, Volume: 11, Issue:14 Topics: Adolescent; Basal Ganglia Diseases; Calcium; Dantrolene; Fever; Haloperidol; Humans; Male; Malignant Hyperthermia; Muscle Rigidity	1982
Single photon emission computed tomography with 123I-IMP in three cases of the neuroleptic malignant syndrome. Neuroradiology, 1994, Volume: 36, Issue:4 Topics: Adult; Amphetamines; Antipsychotic Agents; Basal Ganglia; Brain; Dantrolene; Dose-Response Relationship, Drug; Haloperidol; Humans; Intellectual Disability; Iofetamine; Male; Methotrimeprazine; Neuroleptic Malignant Syndrome; Neurologic Examination; Regional Blood Flow; Schizophrenia; Tomography, Emission-Computed, Single-Photon	1994
Catheter-associated central venous thrombosis. Tennessee medicine : journal of the Tennessee Medical Association, 1996, Volume: 89, Issue:9 Topics: Adult; Bipolar Disorder; Catheterization, Central Venous; Dantrolene; Female; Fluid Therapy; Haloperidol; Humans; Malignant Hyperthermia; Pulmonary Embolism; Subclavian Vein; Thrombosis	1996
Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level. Brain research, 1996, Dec-16, Volume: 743, Issue:1-2 Topics: Animals; Antipsychotic Agents; Atropine; Body Temperature Regulation; Cholinergic Antagonists; Creatine Kinase; Dantrolene; Disease Models, Animal; Dopamine Antagonists; Electromyography; Haloperidol; Hot Temperature; Male; Muscle Relaxants, Central; Muscle Rigidity; Neuroleptic Malignant Syndrome; Rabbits	1996
[A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. Masui. The Japanese journal of anesthesiology, 1997, Volume: 46, Issue:4 Topics: Adult; Antipsychotic Agents; Anxiety; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Chlorpromazine; Dantrolene; Haloperidol; Humans; Injections, Intravenous; Male; Malignant Hyperthermia; Pain, Postoperative; Syndrome	1997
The effects of the atypical antipsychotics clozapine, remoxipride and risperidone on the contractile characteristics of rat skeletal muscle in vitro. Pharmacological research, 1997, Volume: 36, Issue:6 Topics: Animals; Antipsychotic Agents; Caffeine; Clozapine; Dantrolene; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Halothane; In Vitro Techniques; Muscle Contraction; Muscle Relaxants, Central; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Remoxipride; Risperidone; Trifluoperazine	1997
Dantrolene sodium reverses the increase in cAMP response element and TPA responsive element DNA-binding activity in the rabbit brain following haloperidol administration and heat stress. Psychiatry and clinical neurosciences, 1997, Volume: 51, Issue:6 Topics: Animals; Antipsychotic Agents; Brain Chemistry; Cyclic AMP Response Element-Binding Protein; Dantrolene; DNA; Haloperidol; Heat Stress Disorders; Hypothalamus; Male; Muscle Relaxants, Central; Neostriatum; Rabbits	1997
Neuroleptic malignant syndrome in a burn patient. Burns : journal of the International Society for Burn Injuries, 1998, Volume: 24, Issue:6 Topics: Accidents, Occupational; Adult; Antipsychotic Agents; Bromocriptine; Burns; Dantrolene; Debridement; Delirium; Dopamine Agonists; Fever; Follow-Up Studies; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Surgical Wound Infection	1998
Neuroleptic malignant syndrome in an adolescent head trauma patient. Clinical pediatrics, 1999, Volume: 38, Issue:10 Topics: Accidents, Traffic; Adolescent; Age Factors; Anti-Dyskinesia Agents; Bromocriptine; Craniocerebral Trauma; Dantrolene; Female; Haloperidol; Humans; Motorcycles; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome	1999
[Malignant neuroleptic syndrome after haloperidol administration]. Der Anaesthesist, 2001, Volume: 50, Issue:5 Topics: Aged; Antipsychotic Agents; Catecholamines; Critical Care; Dantrolene; Depressive Disorder; Haloperidol; Humans; Liver Function Tests; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome	2001
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:4 Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Fluid Therapy; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Piperazines; Self-Injurious Behavior; Sodium Bicarbonate; Thiazoles	2006
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. Anaesthesia, 2012, Volume: 67, Issue:9 Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Creatine Kinase; Dantrolene; Disseminated Intravascular Coagulation; Female; Genetic Variation; Hallucinogens; Haloperidol; Halothane; Humans; Multiple Organ Failure; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Recurrence; Rhabdomyolysis; Ryanodine Receptor Calcium Release Channel; Spectrum Analysis; Young Adult	2012
Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2016, Volume: 136, Issue:6 Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans; Hydroxyzine; Infusions, Intravenous; Interdisciplinary Communication; Male; Neuroleptic Malignant Syndrome; Patient Care Team; Pharmaceutical Services; Treatment Outcome; Young Adult	2016
[Prolonged neuroleptic malignant syndrome after Haloperidol injection]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2018, Volume: 113, Issue:3 Topics: Antipsychotic Agents; Dantrolene; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Rhabdomyolysis	2018
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome. Journal of emergency nursing, 2018, Volume: 44, Issue:2 Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dantrolene; Diagnosis, Differential; Fentanyl; Haloperidol; Humans; Levetiracetam; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Phenytoin; Piracetam	2018
Neuroleptic malignant syndrome in a COVID-19 patient. Brain, behavior, and immunity, 2020, Volume: 88 Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia	2020
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012